Plunkett Research Online: Ironwood Pharmaceuticals Inc

IRONWOOD PHARMACEUTICALS INC (IRWD:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ironwood Pharmaceuticals, Inc. is a development stage biopharmaceutical firm that discovers, develops and plans to market innovative medicines. The company’s leading product, linaclotide, is a potential treatment for patients with irritable bowel syndrome with constipation (IBS-C) or chronic consti.....



Ironwood Pharmaceuticals Inc
Ticker: IRWD
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 621-7722
Fax: 617 494-0480
Address: 301 Binney Street
Cambridge, MA 02142 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Discovery & Development
ContactsDescription
Peter HechtCEO/Director
Gina ConsylmanCFO/Senior VP
See More
Ironwood Pharmaceuticals, Inc. is a development stage biopharmaceutical firm that discovers, develops and plans to market innovative medicines. The company’s leading product, linaclotide, is a potential treatment for patients with irritable bowel syndrome with constipation (IBS-C) or chronic consti.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Ropes & Gray LLP
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
LINZESS
Zurampic
IW-3718
IW-1973
IW-1701
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: